[New perspective in the medical management of primary hyperparathyroidism].
Most of the medical proposed for patients with primary hyperparathyroidism are inefficient or dangerous, with the exception of oestrogens and physiological doses of vitamin D in selected cases. PTH analogs, calcimimetic drugs and anti-PTH immunization now provide attractive management perspectives.
Wémeau
J L
JL
Clinique Endocrinologique Marc Linquette USNA, CHRU, 59037 Lille Cedex, France.
Fayard
A
A
D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000517:prevention & control; D006961:Hyperparathyroidism / Q000150:complications / Q000188:drug therapy*; D007114:Immunization; D010281:Parathyroid Hormone / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D010281:Parathyroid Hormone; D014807:Vitamin D